Abstract:Background: Cytoskeleton-associated protein 2-like protein (CKAP2L) is thought to promote the progression of glioma, breast cancer, and ovarian cancer. However, the role of cytoskeleton-associated protein 2-like protein in clear cell renal cell carcinoma (ccRCC) is still unclear. The study aimed to investigate the roles and mechanisms of cytoskeleton-associated protein 2-like protein in clear cell renal cell carcinoma. Methods: The level of cytoskeleton-associated protein 2-like protein in tumors was explored by using UALCAN and Oncomine databases. Gene expression datasets of clear cell renal cell carcinoma from The Cancer Genome Atlas and Gene Expression Omnibus (GEO) were also used to validate the cytoskeleton-associated protein 2-like protein level in clear cell renal cell carcinoma. Survival analysis was performed to investigate the relationship between cytoskeleton-associated protein 2-like protein level and prognosis of clear cell renal cell carcinoma patients. Cox regression analysis was used for identifying the independent prognostic factors. Gene set enrichment analysis (GSEA), gene set variation analysis (GSVA), protein–protein interaction analysis, co-expression analysis, and immune infiltration analysis were used to explore the potential mechanisms of cytoskeleton-associated protein 2-like protein in clear cell renal cell carcinoma. Moreover, the levels of cytoskeleton-associated protein 2-like protein in clinical clear cell renal cell carcinoma tissues were also measured using RT-PCR, immunohistochemical analysis, and Western blotting. M1 macrophages and CD4 + T cells were also detected by immunohistochemistry between tumor and normal tissues. Results: The level of cytoskeleton-associated protein 2-like protein was upregulated in clear cell renal cell carcinoma according to multiple databases and experimental verification. Upregulated cytoskeleton-associated protein 2-like protein is an independent prognostic factor, which might activate the JAK–STAT signaling pathway, the P53 signaling pathway, the TGF-β signaling pathway, the WNT signaling pathway, etc. , in clear cell renal cell carcinoma. Protein–protein interaction analysis and co-expression analysis suggest that cytoskeleton-associated protein 2-like protein might interact with some proliferation proteins. Immune infiltration analysis indicates that cytoskeleton-associated protein 2-like protein may affect the level of activated CD4 + memory T cells, M1 macrophages, CD8 + T cells, and neutrophils in clear cell renal cell carcinoma. More M1 macrophage infiltrations in tumor tissues with higher cytoskeleton-associated protein 2-like protein were validated by clear cell renal cell carcinoma tumor tissues. Conclusion: Cytoskeleton-associated protein 2-like protein is upregulated in clear cell renal cell carcinoma tissues, which may promote progression of the disease. Cytoskeleton-associated protein 2-like protein is a potential target for prognostic markers and a potential treatment target in clear cell renal cell carcinoma.

Role of CD2-associated protein and nephrin expression in multilocular cystic renal cell carcinoma

A Clinical Analysis of Multilocular Cystic Renal Cell Carcinoma and Its Correlation with Mutation of the Von Hippel-Lindau Gene

Significance of Cyclin D1、Cyclin E and p21cip1 mRNA Expression in Renal Cell Carcinoma

Cystic renal cell carcinoma: a report of 67 cases including 4 cases with concurrent renal cell carcinoma

Diagnosis and Treatment of Multilocular Cystic Renal Cell Carcinoma:A Study of 22 Cases

Clinical and pathological analysis of multilocular cystic renal cell carcinoma

CD2AP is a potential prognostic biomarker of renal clear cell carcinoma

AB114. Analyses of 77 Multilocular Cystic Renal Cell Carcinoma Cases from a Single Center

T and NK cell abundance defines two distinct subgroups of renal cell carcinoma

Expression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathy

Clinical and Pathological Feature and Prognosis for Multilocular Cystic Renal Cell Carcinoma

Prognostic significance of CKAP2L expression in patients with clear cell renal cell carcinoma

[Expression of Ksp-cadherin in Renal Epithelial Neoplasm and Its Clinicopathologic Significance].

Research in Pathology, Clinical and Imaging Diagnosis of Multilocular Cystic Renal Cell Carcinoma

[Expressions of CMTM8 and E-cadherin in Primary and Metastatic Clear Cell Renal Cell Carcinoma].

Diagnosis and treatment of cystic renal cell carcinoma: a study of 32 cases

Expression and roles of cyclin T1 and β-catenin in renal clear cell carcinoma

Multilocular Cystic Renal Cell Neoplasm of Low Malignant Potential: A Series of 76 Cases.

The Expression of Platelet Vascular Endothelia Cell Adhesion Molecule-31 in Renal Cell Carcinoma

Multilocular cystic renal cell carcinoma: an experience of clinical management for 31 cases

CXC Chemokine Receptor 2 is Associated with Postoperative Recurrence and Survival of Patients with Non-Metastatic Clear-Cell Renal Cell Carcinoma.